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Adipose tissue (AT) of obesemice and humans accu-
mulates immune cells, which secrete cytokines that
can promote insulin resistance. AT macrophages
(ATMs) are thought to originate from bone-marrow-
derived monocytes, which infiltrate the tissue from
the circulation. Here, we show that a major fraction
of macrophages unexpectedly undergo cell division
locally within AT, as detected by Ki67 expression
and 5-ethynyl-20-deoxyuridine incorporation. Macro-
phages within the visceral AT (VAT), but not those in
other tissues (including liver and spleen), displayed
increased proliferation in obesity. Importantly, deple-
tion of blood monocytes had no impact on ATM con-
tent, whereas their proliferation in situ continued.
Treatment with monocyte chemotactic protein 1
(MCP-1) induced macrophage cell division in AT
explants, whereas mcp-1 deficiency in vivo
decreased ATM proliferation. These results reveal
that, in addition to blood monocyte recruitment,
in situ proliferation driven by MCP-1 is an important
process by which macrophages accumulate in the
VAT in obesity.
INTRODUCTION
Obesity can induce an insulin-resistant state in adipose tissue
(AT), liver, and skeletal muscle and is a strong risk factor for
the development of type 2 diabetes (Guilherme et al., 2008;
Olefsky and Glass, 2010). It is increasingly appreciated that the
accumulation of macrophages and other immune cell types in
AT correlates with a chronic inflammatory state that ultimately
impairs adipocyte function and may contribute to the develop-
ment of insulin resistance (Aouadi et al., 2013;Olefsky and Glass,
2010; Weisberg et al., 2003).
The origin of macrophages in AT has previously been attrib-
uted to the recruitment of blood monocytes into AT on the basis
of one study using irradiation followed by bone marrow trans-
plant (Weisberg et al., 2003). Therefore, strategies to decrease
AT macrophage (ATM) accumulation have been particularly
focused on decreasing macrophage migration into the AT by
depleting blood monocytes or genes encoding chemokines162 Cell Metabolism 19, 162–171, January 7, 2014 ª2014 Elsevier Inthat attract macrophages into the AT (Feng et al., 2011; Kanda
et al., 2006; Nomiyama et al., 2007; Weisberg et al., 2006).
However, studies using these approaches do not address
whether migration is the only process contributing to macro-
phage accumulation in the AT. The present study was designed
to determine whether significant macrophage cell division also
occurs within visceral AT (VAT) in mice.
RESULTS AND DISCUSSION
Macrophages Proliferate Locally within the Adipose
Tissue
To confirm macrophage accumulation in AT of obese mice, we
used 8- to 12-week-old genetically obese (ob/ob) male mice
and their lean control wild-type (WT) littermates. The stromal-
vascular fraction (SVF) from VAT and subcutaneous AT (SAT)
was stained with antibodies against macrophage markers, F4/
80 and CD11b, an eosinophil marker, Siglec-F, and a neutrophil
marker, Gr-1, and analyzed with flow cytometry. The macro-
phage population in the AT was defined as F4/80+/CD11b+/
Siglec-F–/Gr-1– (for the complete gating scheme, see Figure S1A
available online). Consistent with published studies (Weisberg
et al., 2003; Xu et al., 2003), macrophage content was signifi-
cantly increased in the VAT of ob/ob in comparison to WT
mice (ob/ob 959 ± 69 3 103 versus WT 140 ± 35 3 103 macro-
phages per g of VAT, p < 0.001; Figures 1A and 1B). The number
as well as the percentage of macrophages was also increased in
the SAT of ob/ob in comparison to WTmice but to a lower extent
than in VAT (ob/ob 192 ± 31 3 103 versus WT 109 ± 12 3 103
macrophages per g of SAT, p = 0.04; Figure S1B). These results
confirmed that macrophages accumulate mostly in the VAT in
mice in response to obesity.
To test whether ATM proliferation increases in the inflamma-
tory setting of obesity, SVF cells from WT and ob/ob mice
were stained with an antibody against the proliferation marker
Ki67, which is a protein expressed during all active phases of
the cell cycle (Scholzen and Gerdes, 2000). Ki67 signal was
detected in approximately 2.3% of ATMs from VAT of lean WT
mice and in 10% of ATMs of ob/ob mice (ob/ob 94 ± 7 3 103
versus WT 7.6 ± 3.2 3 103 macrophages per g of VAT, p <
0.001; Figures 1C and 1D). The percentage of Ki67+ macro-
phages was also increased in the SAT from ob/ob in comparison
to WT mice (Figure S1C). However, the number of Ki67+ macro-
phages was lower in SAT in comparison to VAT in ob/ob mice
(SAT 20.0 ± 3.3 3 103 versus VAT 94 ± 7 3 103 macrophages
per g, p < 0.001). This suggests that macrophages preferentiallyc.
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with the flow cytometry analysis, immunofluorescence micro-
scopy on SVF cells and VAT of ob/ob mice showed macro-
phages expressing Ki67 in their nuclei (Figures 1E and 1F).
Interestingly, most of the Ki67 staining was observed in macro-
phages in a region of the VAT rich in macrophages termed
crown-like structures (CLSs) (Figure 1F).
Similar to genetically induced obesity, diet-induced obesity
increased macrophage content in the AT (Figures 1G and 1H).
ATM number was significantly higher in SVF of VAT in mice fed
a high-fat diet (HFD) in comparison to normal chow diet (ND)
(HFD 1,045 ± 1313 103 versus ND 140 ± 353 103 macrophages
per g of VAT, p < 0.001). More importantly, in mice fed an HFD,
17% of ATMs were Ki67+ in comparison to 3% in mice fed an ND
(HFD 183 ± 213 103 versus ND7.6 ± 3.23 103macrophages per
g of VAT, p < 0.001; Figures 1 I and 1J). Consistent with pub-
lished data (Bourlier et al., 2008), and as suggested by gene
expression profile analysis of human ATMs (Mayi et al., 2012),
flow cytometry analysis of SVF stained with Ki67 antibody
showed that approximately 8% of ATMs proliferate in AT
(7.7% ± 1.9%, n = 5; Figure 1K). Altogether, with the use of
flow cytometry and microscopic analysis, these results show
that macrophages express the proliferation marker Ki67 in the
AT in mice and humans and, to a higher degree, in response to
obesity caused by either genetic manipulation or an HFD inmice.
Next, we tested whether fasting-induced weight loss also
regulates ATM proliferation. After a 24 hr fast, mice lost an
average of 5 percent body weight (data not shown). Although
the percentage of ATM was slightly decreased, the number of
ATMwas significantly decreased in VAT of mice fed an HFD after
a 24 hr fast (Figures 1L and 1M). Although this could be explained
by a concomitant decrease in nonmacrophage cells, it has been
shown that fasting induces the formation of lipid-laden macro-
phages attached to the adipocyte fraction (Kosteli et al., 2010).
Interestingly, ATM proliferation was significantly decreased after
a 24 hr fast, suggesting a correlation between macrophage con-
tent and proliferation in the AT (Figure 1N).
It is interesting to note that fasting had no effect on the prolif-
eration of F4/80/CD11b cells, which could include cell types
that have been shown to proliferate in situ in the AT, including
T cells (Morris et al., 2013a) and adipocyte progenitors (Lee
et al., 2012) (Figure 1O). Altogether, these results suggest that
changes occurring during AT mass regulation selectively affect
proliferation of specific cell types in AT, including macrophages.
Obesity Stimulates Macrophage Proliferation
Specifically in the Adipose Tissue
To test whether macrophage proliferation increases with obesity
in tissues other than AT, we analyzed the proliferation rate of
macrophages in the spleen and liver after a 3 hr pulse of the
nucleoside analog to thymidine, 5-ethynyl-20-deoxyuridine
(EdU), which is incorporated into DNA only during the S phase.
Approximately 1% of ATMs in lean mice and about 4.5% of
the macrophages in the obese mice were in S phase during
the pulse of EdU (Figure 2A), confirming that obesity increases
ATM proliferation. In contrast, less than 2% of all cells, including
macrophages, were EdU+ in spleen and liver, and there was no
difference in EdU+ cells between lean and obese mice in these
tissues (Figures 2B and 2C). This striking specificity for increasedCellmacrophage proliferation in AT in obesity implies that the AT
microenvironment is important for macrophage proliferation.
Monocytes failed to display detectable EdU incorporation
within the 3 hr pulse in lean or obese mice, suggesting that
EdU+macrophages observed in the AT are not recently recruited
blood monocytes (Figure 2D). Importantly, obesity did not affect
the EdU incorporation rate in spleen, liver, or blood macro-
phages (Figure 2E). Interestingly, macrophage content in-
creased with obesity in AT (Figure 1A), whereas there was no
change or a slight decrease in spleen or liver in ob/ob mice in
comparison to WT mice (Figure 2F). Furthermore, this confirms
a correlation between macrophage accumulation and prolifera-
tion in tissues and suggests that AT provides a unique environ-
ment facilitating macrophage proliferation.
In order to study the selective effect of obesity on immune
cell proliferation, we analyzed Ki67 staining in eosinophils and
neutrophils, whose content in the AT has been shown to be
regulated by obesity (Talukdar et al., 2012; Wu et al., 2011).
Consistent with a prior report (Wu et al., 2011), we found that
eosinophil content relative to macrophages in the AT decreased
with obesity (Figures S2A–S2C). Neutrophil content in AT was
not significantly different between WT and ob/ob mice (Figures
S2D–S2F). Although both eosinophils and neutrophils have
been shown to have some proliferative capacity outside of the
bone marrow (Bjornson et al., 1985; Yang and Renzi, 1993), we
failed to detect any EdU incorporation into these cells within
AT (Figures S2C and S2F). Our results suggest that obesity
does not stimulate the proliferation of all cells in the AT but selec-
tively stimulates the proliferation of specific cell types, including
macrophages.
Macrophage Proliferation Contributes to Adipose
Tissue Inflammation Independently of Monocyte
Recruitment
Next, to further ensure that the proliferating macrophages in the
AT were not recently recruited EdU+ blood monocytes, we stud-
ied the capacity of ATMs to proliferate ex vivo. SVF cells isolated
from VAT of lean and obese mice were plated and treated with
EdU for 3 hr. Approximately 0.3% of the ATMs from lean mice
were EdU+, whereas >2% were positive in macrophages from
obese mice (Figures S3A and S3B). These results suggest that
ATMs have the inherent capacity to proliferate ex vivo indepen-
dently of blood monocyte recruitment. To test this hypothesis,
we depleted blood monocytes in ob/ob mice by intravenous
(i.v.) injection of clodronate-loaded liposomes (Clod-Lipo), which
induce apoptosis once ingested by monocytes (Feng et al.,
2011). Consistent with published studies, Clod-Lipo i.v. injection
depleted about 80% of blood monocytes 16 hr after injection in
comparison to a PBS-liposome (PBS-Lipo) injection (Figures 3A
and 3B). Then, we injected ob/ob mice every 16 hr with Clod-
Lipo in order to maintain blood monocyte depletion and
measured macrophage content in the VAT. Unexpectedly,
ATM absolute number (48 hr, PBS-Lipo 3.78 ± 0.37 versus
Clod-Lipo 3.88 ± 0.35; 96 hr, PBS-Lipo 4.54 ± 0.60 versus
Clod-Lipo 3.36 ± 0.11 3106 cells per g of VAT) and ATM per-
centage in the SVF were unchanged with Clod-Lipo treatment
even after prolonged blood monocyte depletion (Figure 3C).
These data raised the possibility that the increase in macro-
phages that occurs during obesity was largely the result of theMetabolism 19, 162–171, January 7, 2014 ª2014 Elsevier Inc. 163
Figure 1. Adipose Tissue Macrophages Express the Cell Division Marker Ki67
SVF from VAT of WT and ob/ob mice was isolated and analyzed by flow cytometry.
(A) Representative flow cytometry dot plots.
(B) Percentage of macrophages in SVF.
(C) Representative flow cytometry dot plots of ATMs stained with Ki67.
(legend continued on next page)
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Figure 2. Obesity Increases Macrophage
Proliferation Specifically in Adipose Tissue
(A–D) WT and ob/ob mice were intraperitoneal
injected with EdU, and AT (A), spleen (B), liver (C),
and blood (D) were collected and digested 3 hr
after treatment. All cells were stained and
analyzed by flow cytometry. Representative dot
plots depict the EdU incorporation into all cells of
the respective tissues or blood monocytes.
(E) Mean percentage of EdU incorporation rate of
the macrophages of each tissue ± SEM.
(F) Percentage of macrophages in each tissue. n =
14–15 from three independent experiments for AT
and blood, and n = 9–10 from two independent
experiments for spleen and liver. Statistical
significance was determined by a Student’s t test.
***p < 0.001.
See also Figure S2.
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Macrophage Cell Division in Adipose Tissueproliferation of the resident population. Therefore, ob/ob mice
were given EdU in drinking water during monocyte depletion,
as depicted in the diagram in Figure 3D. About half of the mac-
rophages in the AT of ob/ob mice injected with PBS-Lipo had
incorporated EdU 80 hr after EdU exposure (Figures 3E and
3F). Importantly, the depletion of blood monocytes had no effect
onmacrophage proliferation, as observed by the EdU incorpora-
tion in the VAT of ob/obmice injected with Clod-Lipo (Figures 3E
and 3F). Interestingly, no difference in EdU incorporation was
observed in macrophages in SAT of ob/ob in comparison to
WTmice after 80 hr of EdU exposure (Figure 3G). This suggested
that macrophage proliferation plays a major role in VAT
macrophage expansion in obesity independently of monocyte
recruitment. However, recently recruited macrophages may(D) Percentage of macrophages expressing Ki67. n = 30–31 from six independent experiments.
(E) Microscopy of plated SVF stained with antibodies against F4/80 (red) and Ki67 (green). Nuclei were staine
scale bar represents 5 mm.
(F) VAT of ob/ob mice containing CLS stained with antibodies against F4/80 (red) and Ki67 (green). Nuclei
images. The scale bar represents 40 mm.
(G) SVF from VAT of mice fed an ND or HFD for 7 weeks was isolated and analyzed by flow cytometry. Rep
(H) Mean percentage of macrophages in SVF.
(I) Representative flow cytometry dot plots of ATMs stained with Ki67.
(J) Percentage of macrophages expressing Ki67. n = 30–31 from six independent experiments.
(K) Representative dot plot of SVF from human SAT stained with Ki67.
(L) Percentage of macrophages in SVF from VAT of mice fed an HFD for 7 weeks and fasted for 24 hr. n = 8
(M) Number of macrophages in SVF from VAT of mice fed an HFD and fasted for 24 hr. n = 5.
(N) Percentage of macrophages expressing Ki67 in fasted mice. n = 8–18.
(O) Percentage of nonmacrophages (CD11b/F4/80) expressing Ki67. n = 8–18. All graphs are express
determined by a Student’s t test. ***p < 0.001; **p < 0.01; *p < 0.05.
See also Figure S1.
Cell Metabolism 19, 162–17also proliferate in AT of obesemice, given
that a recent study showed that 5% of
labeled blood monocytes transferred
from donor into recipient mice express
Ki67 in the host AT 2 days after transfer
(Oh et al., 2012).
Although macrophage subpopulations
in the AT may have overlapping marker
expression profiles, it is generally thought
that CD11c expression is characteristic ofproinflammatory macrophage subtypes (Lumeng et al., 2008).
Therefore, we analyzed the rate of proliferation of proinflamma-
tory (CD11c+) and anti-inflammatory (CD11c) macrophages
(Figure S3C). We failed to observe any difference in the rate of
proliferation of macrophage population subtypes. This suggests
that obesity increases macrophage proliferation rate indepen-
dently of their inflammatory state. It has been previously shown
that CLS density is higher in the VAT in comparison to SAT in
obesemice (Muranoet al., 2008). Interestingly,microscopic anal-
ysis of VAT sections showed that EdUwasmostly incorporated in
macrophages in CLS (Figure 3H). Altogether, these results sug-
gest that ATMproliferation occurs at a high rate in the VAT,where
macrophage content and CLS density are greatly increased by
obesity.d with DAPI (blue). 633magnification images. The
were stained with DAPI (blue). 203 magnification
resentative flow cytometry dot plots.
–18.
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Figure 3. Adipose Tissue Macrophages Proliferate Independently of Monocyte Recruitment
(A and B) Example flow cytometry dot plots of CD11b+ blood cells show the depletion of monocytes.
(B) The quantitation of blood monocytes expressed as a percentage of total blood cells. n = 10 for 16–48 hr of liposome treatment, and n = 4–5 for the 96 hr time
point.
(C) Macrophage content in the AT of PBS-Lipo- and Clod-Lipo-treated ob/obmice. n = 5 mice per group. 18 hr after initial injection, the mice were given drinking
water containing EdU.
(D) Diagram representing the experimental design of the treatment.
(E and F) Representative flow cytograms (E) and quantificationn (F) of EdU incorporation into ATMs during 32 and 80 hr of exposure to EdU drinking water in PBS-
Lipo-treated and monocyte-depleted Clod-Lipo-treated ob/ob mice.
(G) Quantification of EdU incorporation into ATMs during 80 hr of exposure to EdU drinking water in VAT and SAT in leanWT and ob/ob obesemice. n = 5mice per
group. All graphs are expressed as mean ± SEM. Statistical significance was determined by a Student’s t test or two-way ANOVA followed by a Tukey post hoc
test. ***p < 0.001; **p < 0.01; *p < 0.05.
(H) VAT of ob/ob mice containing CLS stained with antibodies against F4/80 (red) and EdU (green). Nuclei were stained with DAPI (blue). 203 magnification
images. The scale bar represents 40 mm.
ob/ob mice were i.v. injected with either PBS-Lipo or Clod-Lipo every 16 hr. See also Figure S3.
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Macrophage Cell Division in Adipose TissueMCP-1 Stimulates Adipose Tissue Macrophage
Proliferation
To investigate the mechanism by which obesity stimulates
macrophage proliferation selectively in the AT, we measured
the expression of multiple cytokines known to play a role in
macrophage proliferation and infiltration in the AT and liver of
lean (ND and WT) and obese (HFD and ob/ob) mice. These
included interleukin 4 (IL-4) (Jenkins et al., 2011), macrophage
colony-stimulating factor (M-CSF) (Hashimoto et al., 2013),
osteopontin (OPN) (Nomiyama et al., 2007), and monocyte
chemotactic protein (also referred to as chemokine [C-C motif]
ligand 2 [CCL2/MCP-1]) (Kanda et al., 2006; Weisberg et al.,
2006) (Figures 4A–4D and S4A–S4D). Only opn and MCP-1
expression were significantly increased with obesity (Figures
4A–4D and S4A–S4D). As described in Figures 1 and 2, macro-
phage proliferation was mainly increased in VAT in obese mice
compared to lean mice; therefore, we measured the expression
of opn and mcp-1 in this fat depot in comparison to SAT and
liver, where ATM proliferation is minimal (Figures 4E and 4F).
Although opn expression was unchanged in SAT with obesity,
it was significantly increased in the liver (Figure 4E). In addition,
opn expression was similar in liver and VAT in mice fed an HFD
(Figure 4E). In contrast, mcp-1 expression was significantly
higher in VAT in comparison to liver and SAT in obese mice (Fig-
ure 4F). In addition, MCP-1 was the only cytokine that was
decreasedwith fasting, which was consistent with a recent study
(Asterholm et al., 2012) (Figures 4G and S4E). This suggests a
positive correlation between mcp-1 expression and macro-
phage proliferation in mice.
On the basis of the above analysis, the expression of mcp-1
in adipocytes and SVF from VAT of mice fed an HFD was
measured. Although mcp-1 expression was high in both frac-
tions, it was significantly higher in the adipocytes (Figure S4F).
Interestingly the MCP-1 receptor, chemokine (C-C motif) recep-
tor 2 (CCR2), has been shown to be mostly expressed in macro-
phages in CLS where most of proliferating ATMs were observed
(Lumeng et al., 2008). These results suggest that MCP-1
released by adipocytes in CLS could stimulate the proliferation
of surrounding ATMs.
In order to test whether MCP-1 regulates ATM proliferation,
mice lacking the mcp-1 gene and their WT littermates were fed
an HFD and ATM content, and proliferation was measured in
the VAT after 30 hr of EdU administration in drinking water
(Figures 4H–4K). HFD-induced obesity significantly increased
ATM content, whereas fasting decreased the percentage of
macrophages in the VAT (Figures 4H and 4I). Most importantly,
we observed a significant decrease in the percentage and num-
ber of macrophages in the VAT from MCP-1 knockout (KO) in
comparison to WT (Figures 4H and 4I). RT-PCR analysis re-
vealed that emr1 and cd11b expression was decreased in the
VAT of MCP-1 KO in comparison to WT mice fed an HFD, con-
firming the decreased ATM content (Figure S4G). In addition,
mcp-1 deficiency was associated with a decrease in the total
number of SVF cells (WT-HFD, 1,836.78 ± 256.77 versus MCP-
1 KO, 287.96 ± 74.40), suggesting a general effect of MCP-1
on immune cell accumulation in AT, as suggested in other tissues
(Allavena et al., 1994; Jimenez et al., 2010). On the other hand,
macrophages in the adipose tissue have been shown to play
the role of antigen-presenting cells able to induce T cell prolifer-Cellation (Morris et al., 2013b), suggesting that the decreased ATM
accumulation observed in MCP-1 KO mice could result in
decreased T cell proliferation. Interestingly, fasting had no addi-
tional effect on ATM content in MCP-1 KO, suggesting that
MCP-1 could be a major regulator of macrophage content in
the VAT (Figures 4H and 4I). EdU staining analysis showed that
the percentage and number of EdU+ ATMs decreases with
fasting and mcp-1 deficiency, suggesting that the decrease in
ATM content observed in MCP-1 KO mice could be due to a
decreased rate of proliferation (Figures 4J and 4K). Interestingly,
mcp-1 deficiency had no effect on the percentage of macro-
phages in liver and SAT, confirming the selective role of
MCP-1 in the regulation of macrophage content in the VAT
(Figure S4H).
Although MCP-1 has been shown to stimulate proliferation of
multiple cell types (Hinojosa et al., 2011; Sager et al., 2010), it
has been extensively described as a chemokine attracting
macrophages from the blood to the AT in obese mice (Kanda
et al., 2006; Weisberg et al., 2006). Thus, to test whether
MCP-1 regulates ATM proliferation independently of macro-
phage recruitment, the monocyte content in the blood of
MCP-1 KO andWTmice was analyzed (Figure 4L). We observed
an increase in circulating monocytes in control mice with HFD in
comparison to ND (Figure 4L), suggesting that monocyte recruit-
ment contributes to macrophage accumulation in the AT. How-
ever, monocyte number in the blood remained the same in fed
and fasted states in MCP-1 KO and WT mice, indicating that
fasting-associatedMCP-1 decrease orMCP-1 deficiency lowers
ATM content mostly by decreasing proliferation (Figure 4L). To
test this hypothesis, we measured EdU incorporation in ATM in
VAT explants from ob/ob mice treated with MCP-1. Consistent
with the hypothesis that MCP-1 regulates the accumulation of
multiple cell types, the treatment of explants with MCP-1
ex vivo increased the total number of SVCs (untreated,
1,961.15 ± 788.00 versus MCP1 [10 ng/ml], 4,404.80 ±
353.66). Importantly, MCP-1 treatment significantly increased
the number of ATMs and EdU incorporation (Figures 4M and
4N). Although proliferation may be regulated by multiple factors,
MCP-1 plays a major role in regulating macrophage proliferation
in the AT of obese mice independently of monocyte recruitment.
However, these data do not exclude the contribution of mono-
cyte recruitment and subsequent proliferation in the AT in
obesity.
Next, body weight, glucose tolerance, and fasting glycaemia
were measured in MCP-1 KO and WT mice fed an HFD in order
to assess the metabolic consequences of a decreased ATM
proliferation (Figures 4O–4Q). The body weight of MCP-1 KO
was slightly, but not significantly, higher than WT mice fed an
HFD, and both were significantly higher than WT mice fed an
ND (Figure 4O). Surprisingly, although mcp-1 deficiency led to
a lower rate of macrophage proliferation in the AT and conse-
quently a decreased ATM content, glucose intolerance was
exacerbated inMCP-1 KO in comparison toWTmice (Figure 4P).
Similarly, fasting blood glucose levels were significantly elevated
in MCP-1 KO in comparison to WT mice (Figure 4Q). This result
corroborated data from a previous study showing that MCP-1
KO mice fed an HFD are more glucose intolerant that their WT
littermates (Inouye et al., 2007). However, Inouye et al. (2007)
showed that macrophage content is slightly increased in theMetabolism 19, 162–171, January 7, 2014 ª2014 Elsevier Inc. 167
(legend on next page)
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Macrophage Cell Division in Adipose TissueVAT of MCP-1 KO in comparison toWTmice. One of the reasons
for this discrepancy could be the gating scheme used to define
macrophages in the AT. In our study, macrophages were defined
as F4/80+/CD11b+/Siglec-F/Gr1 (see the gating scheme in
Figure S1) versus F4/80+/CD11b+, which includes eosinophils
and neutrophils in Inouye et al. (2007).
Altogether, these results show that a decreased ATM prolifer-
ation is associated with exacerbated glucose intolerance.
Although much of the relevant literature suggests that macro-
phages in AT are inhibitory to adipose function (Olefsky and
Glass, 2010), some data indicate a beneficial role, for example,
in increasing adipose lipid storage or clearance of dead cells in
AT (Kosteli et al., 2010; Murano et al., 2008). Although MCP-1
deficiency could regulate glucose tolerance independently of
an effect on ATM proliferation, such as increased body weight
or decreased accumulation of multiple immune cell types, our
results indicate that proliferation may be amechanismmediating
the accumulation of ATM beneficial for glucose tolerance.
In summary, we show that macrophage proliferation within
VAT is a dynamic mechanism that increases with obesity and
decreases during acute weight loss. Given the high proportion
of macrophages (about 50%) that incorporate EdU over
80 hr, proliferation most likely contributes significantly, in
addition to recruitment, to the accumulation of macrophages in
the AT in obesity. At the molecular level, this study reveals
MCP-1 as a potential stimulus for macrophage proliferation in
obese AT.
EXPERIMENTAL PROCEDURES
Animals
We obtained 8- to 12-week-old male WT C57BL/6J and B6.V-Lepob/J (ob/ob)
mice from Jackson Laboratory and maintained on a 12 hr light/dark cycle.
Animals were given free access to food and water. WT C57BL/6J mice were
fed an HFD (45% calories from lipids; D12451, Research Diets) for 7 weeks.
All other mice were fed normal chow diet (Prolab 5P76 Isopro RMH 3000,
LabDiet). We obtained 6-week-old male MCP-1 KO and WT mice on a
C57BL/6J background from the Jackson Laboratory. Mice were fed an HFD
(60% calories from lipids; D12492, Research Diets) for 6 weeks. All procedures
were performed in accordance with protocols approved by the University
of Massachusetts Medical School’s Institutional Animal Care and Use
Committee.
Isolation of Macrophages from Human and Mouse Adipose Tissue
All protocols were approved by the UMass Institutional Review Board. Human
SAT was obtained from discarded tissue of five patients undergoing pannicu-
lectromy at UMassMemorial Hospital. Adipose tissue SVF cells were prepared
from collagenase-digested adipose tissue. In brief, fat pads were digested
with 2 mg/ml collagenase (Sigma-Aldrich) at 37C for 45 min, filtered through
100 mm BD Falcon cell strainers, and spun at 3003 g for 10 min at room tem-Figure 4. MCP-1 Is Required for Optimal Adipose Tissue Macrophage
(A–D) il4 (A), mcsf (B), opn (C), and mcp-1 (D) expression was measured by RT-P
(E and F) Expression of opn (E) and mcp-1 (F) in SAT, VAT, and liver from mice f
(G) Expression of mcp-1 in VAT of mice fed an HFD for 7 weeks and fasted for 2
(H and I) Percentage (H) and number (I) of macrophages in SVF from VAT of MC
(J and K) Percentage (J) and number (K) of EdU+ macrophages in AT of MCP-1 K
(L–N) Number of bloodmonocytes inMCP-1 KO andWTmice (L). Explants from V
10 mM of EdU for 48 hr. Graph represents the number of macrophages (M) and E
(O) Body weight of MCP-1 KO and WT mice fed an HFD for 6 weeks.
(P and Q) GTT (P) and fasting glycaemia (Q). All graphs are expressed as mean ±
ANOVA followed by a Tukey post hoc test. ***p < 0.001; **p < 0.01; *p < 0.05.
VAT was isolated from mice fed am ND or HFD for 7 weeks. See also Figure S4.
Cellperature. The adipocyte layer and the supernatant were aspirated, and the
pelleted cells were collected as the SVF.
Liver and Spleen Cell Isolation
Liver cells were isolated as previously described (Page and Garvey, 1979).
Spleens were manually dissociated, and the resultant cell suspension was
centrifuged at 500 3 g.
Flow Cytometry
For mice, cells were resuspended in PBS containing 1% BSA (fluorescence-
activated cell sorting buffer) and Fc Block (eBioscience) and allowed to block
nonspecific binding for 15 min at 4C. Then, cells were counted and incubated
for an additional 20min in the dark at 4Cwith fluorophore-conjugated primary
antibodies or isotype control antibodies. See the Supplemental Experimental
Procedures for a complete list of the antibodies used.
For the EdU experiments, cells were surface stained according to manu-
facturer’s instructions. After incubation with primary antibodies, cells were
washed and fixed with Fixation/Permeabilization Concentrate buffer
(eBioscience) and then permeabilized with permeabilization buffer
(eBioscience). EdU was chemically conjugated to Alexa 405 or Alexa 647 fluo-
rophore according to the instructions of the manufacturer (Invitrogen). Sample
data were acquired on a BD LSRII flow cytometer (BD Biosciences) and
analyzed with FlowJo (Tree Star).
Liposome Preparation and Depletion of Blood Monocytes
PBS and clodronate-loaded liposomes were prepared in a precisely scaled-
down version of a method previously described (van Rooijen and van
Kesteren-Hendrikx, 2003). ob/obmice were i.v. injected with 200 ml of clodro-
nate-loaded liposomes or an equal volume of PBS-loaded liposomes every
16 hr. Small amounts of blood were taken at the end of several of the 16 hr
periods and immediately before subsequent liposome injection in order to
ensure that monocyte depletion was continuous. Untreated mice did not
receive any injections. The mice were given drinking water containing
1 mg/ml EdU 18 hr after the initial liposome injection. ATM content and EdU
incorporation into ATMs were assessed by flow cytometric analysis 32 and
80 hr after exposure to EdU drinking water.
Explants and Treatments
Pieces (1–2 mm3) of VAT from ob/obmice were treated with 10 mM EdU and 1
or 10 ng/ml of MCP-1 (Invitrogen). After 48 hr of treatment, SVF cells were
isolated, counted, and analyzed by flow cytometry.
Immunohistochemistry
Adipose tissue SVF cells and sections were stained and analyzed by fluores-
cent microscopy as previously described (Aouadi et al., 2013).
Isolation of RNA and Real Time PCR
RNA isolation was performed according to the Trizol Reagent Protocol
(Invitrogen). cDNA was synthesized from 0.5–1 mg of total RNA with an iScript
cDNA Synthesis Kit (Bio-Rad) according to the manufacturer’s instructions.
For real-time PCR, synthesized cDNA forward and reverse primers along
with the iQ SYBR Green Supermix were run on the CFX96 Touch Real-Time
PCR Detection System (Bio-Rad). The ribosomal mRNA 36B4 was used as
an internal loading control.Proliferation
CR. n = 5.
ed an ND or HFD for 7 weeks. n = 5.
4 hr.
P-1 KO and WT mice fed an HFD for 6 weeks and fasted for 18 hr. n = 5.
O and WT mice.
AT of five ob/obmice were treated with 1 and 10 ng/ml of MCP-1 in presence of
dU+ (N) macrophages in explants.
SEM. Statistical significance was determined by a Student’s t test or two-way
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All values are shown as means ± SEM. A Student’s t test for two-tailed distri-
butions with equal variances was used for comparison between two groups.
p % 0.05 was considered significant. Statistical analyses were performed
with GraphPad Prism 5.
Please see the Supplemental Information for detailed experimental proce-
dures and additional data.
SUPPLEMENTAL INFORMATION
Supplemental Information contains Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cmet.2013.11.017.
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